28th Nov 2007 11:11
Cyprotex PLC28 November 2007 Press Release 28 November 2007 Cyprotex PLC ("Cyprotex" or "the Company") Director share purchases Cyprotex PLC (AIM: CRX), the drug discovery technology and information companywas notified today that Robert Morrison Atwater, the Chairman and ChiefExecutive of the Company purchased a total of 225,000 ordinary shares of 0.1peach in the Company on 27 November 2007 at 5.10 pence per share. Robert MorrisonAtwater now has a total interest of 1,835,000 ordinary shares in the Company,which represents 1.32% of the issued share capital of the Company. - Ends - For further information:Cyprotex PLCMark Warburton Tel: +44 (0) 1625 [email protected] www.cyprotex.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L